Evidence map›Paper›PMID 38757110›Full record

ArticleBMJ neurology open2024

Recreational nitrous oxide and thrombotic events: a case series.

Marta Patyjewicz, Devan Mair, Safiya A Zaloum, Barbara Onen, Joseph Walton, Ruth Dobson, Christine Joerres, Apeksha Madhusudan Shah, Peter MacCallum, Thomas H Massey and 4 more

Abstract read
In one paragraph

Article in BMJ neurology open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Marta PatyjewiczRoyal London Hospital, Barts Health NHS Trust, London, UK.ORCID 0009-0008-1717-6922
Devan MairRoyal London Hospital, Barts Health NHS Trust, London, UK.
Safiya A ZaloumRoyal London Hospital, Barts Health NHS Trust, London, UK.
Barbara OnenRoyal London Hospital, Barts Health NHS Trust, London, UK.
Joseph WaltonRoyal London Hospital, Barts Health NHS Trust, London, UK.
Ruth DobsonRoyal London Hospital, Barts Health NHS Trust, London, UK.
Christine JoerresRoyal London Hospital, Barts Health NHS Trust, London, UK.
Apeksha Madhusudan ShahRoyal London Hospital, Barts Health NHS Trust, London, UK.
Peter MacCallumRoyal London Hospital, Barts Health NHS Trust, London, UK.
Thomas H MasseyCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
Tadbir BarianaRoyal London Hospital, Barts Health NHS Trust, London, UK.
Veronica WhiteRoyal London Hospital, Barts Health NHS Trust, London, UK.
Sarah A De FreitasRoyal London Hospital, Barts Health NHS Trust, London, UK.
Alastair NoyceRoyal London Hospital, Barts Health NHS Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The study aimed to elucidate the prevalence of nitrous oxide (N2O) usage in patients with unexplained venous thromboembolism (VTE), highlighting the potential association with hyperhomocysteinaemia (HHcy). Methods: We conducted a retrospective study at the Royal London Hospital, examining cases of N2O-related VTE from March to August 2023. Among 50 patients identified, four (8%) had recent unprovoked VTE. Patient data were collected based on N2O ambulatory emergency care pathway admissions. Results: Among the 50 patients identified, four (8%) had recent or concurrent VTE. Three were male (75%), with an ethnic distribution of 50% Asian or Asian British and 50% Black or Black British. Patients were distributed across quintiles of the index of multiple deprivation. All had actual or functional vitamin B12 deficiency. Discussion: The association between N2O use and VTE requires further investigation, though a plausible mechanism involving HHcy has been proposed. Clinicians should be vigilant for VTE in N2O users, especially those presenting with unexplained symptoms. VTE prophylaxis may be worth considering, particularly if continued exposure to nitrous oxide is anticipated. Conclusion: N2O misuse may increase the risk of VTE, warranting attention from healthcare providers. Further research is needed to elucidate this association and inform preventive strategies. Public awareness about the risks of N2O remains essential.

Indexed as

B12 DEFICIENCYCLINICAL NEUROLOGYSINUS THROMBOSIS

Identifiers

PMID38757110
PMCPMC11097798

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.